Dapagliflozin Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 5mg
Reference Brands: Farxiga(US/EU)
Category:
Diabetes
Dapagliflozin Tablets are SGLT2 inhibitors used to treat type 2 diabetes, heart failure, and chronic kidney disease.
Dapagliflozin is available in Tablet
and strengths such as 5mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dapagliflozin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dapagliflozin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dapagliflozin Tablets are oral antidiabetic medications used to manage type 2 diabetes, heart failure, and chronic kidney disease. As a sodium-glucose co-transporter-2 (SGLT2) inhibitor, Dapagliflozin helps lower blood sugar levels by promoting glucose excretion through urine, while also supporting cardiovascular and renal health. It is marketed under brand names such as Farxiga® in the US and Forxiga® in the EU. Widely prescribed by healthcare professionals, Dapagliflozin Tablets are essential in modern diabetes and nephrology care. Ideal for pharmaceutical importers and distributors, we supply high-quality Dapagliflozin Tablets in bulk for global B2B markets at competitive prices.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing